News
-
-
COMMUNIQUÉ DE PRESSE
VALBIOTIS SA: Valbiotis dévoile ses comptes annuels et confirme ses ambitions stratégiques et financières
Valbiotis SA dévoile ses comptes annuels et confirme ses ambitions stratégiques et financières. La société annonce des résultats solides et une feuille de route ambitieuse jusqu'en 2030 -
COMMUNIQUÉ DE PRESSE
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Valbiotis unveils its annual financial statements & confirms strategic and financial goals for 2027 & 2030. Company reports fiscal year 2024 results indicating progress and transformation -
COMMUNIQUÉ RÉGLEMENTÉ
Déclaration hebdomadaire d'opérations effectuées du 24 au 28 février 2025
-
COMMUNIQUÉ RÉGLEMENTÉ
Disclosure of transactions in own shares from February 24 to February 28, 2025
-
COMMUNIQUÉ DE PRESSE
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
Alzchem Group organizes Creatine Conference 2025 in Munich, bringing together creatine experts for discussions on fatigue, women's health, cognitive performance, and more. Event in hybrid format allowing online attendance -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Delticom AG carries out a further share buyback program in the amount of up to 100,000 own shares
Delticom AG announces new share buyback program of up to 100,000 own shares. The company plans to repurchase shares at a max of EUR 3.00 per share from March 4 to July 5, 2025 -
